Sandu Pharmaceuticals: No Deviation in Use of Funds from Preferential Issue

Sandu Pharmaceuticals Ltd. has reported no deviation in the use of funds raised from the preferential issue. The funds have been utilized towards the revamping of existing capital machinery, developing marketing infrastructure, and purchase of new/additional plant and machinery. The company also allocated funds for working capital requirements, investment in technologies, and general purposes.